The research team used a new CRISPR-based genome editing system named PESpRY.

Scientists in China have effectively treated retinitis pigmentosa.

The research team utilized a novel form of CRISPR-based genome editing that is exceptionally adaptable and could potentially remedy numerous genetic mutations responsible for causing different diseases.